Navigation Links
FDA Approves Eylea for Eye Disorder in Older People
Date:11/18/2011

SILVER SPRING, Md., Nov. 18, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Eylea (aflibercept) to treat patients with wet (neovascular) age-related macular degeneration (AMD), a leading cause of vision loss and blindness in Americans ages 60 and older.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

AMD gradually destroys a person's sharp, central vision. It affects the macula, the part of the eye that allows people to see fine detail needed to do daily tasks such as reading and driving.

There are two forms of AMD, a wet form and a dry form. The wet form of AMD includes the growth of abnormal blood vessels. The blood vessels can leak fluid into the central part of the retina, also known as the macula. When fluid leaks into the macula, the macula thickens and vision loss occurs. An early symptom of wet AMD occurs when straight lines appear to be wavy.

"Eylea is an important new treatment option for adults with wet AMD," said Edward Cox, M.D., M.P.H, director of the Office of Antimicrobial Products in FDA's Center for Drug Evaluation and Research. "It is a potentially blinding disease and the availability of new treatment options is important."

The safety and effectiveness of Eylea was evaluated in two clinical trials involving 2,412 adult patients. People in the study received either Eylea or Lucentis (ranibizumab injection). The primary endpoint in each study was a patient's clearness of vision (visual acuity) after one year of treatment.

Eylea is injected into the eye either every four weeks or every eight weeks by an ophthalmologist. The studies showed that Eylea was as effective as Lucentis in maintaining or improving visual acuity.  

The most commonly reported side effects in patients receiving Eylea included eye pain, blood at the injection site (conjunctival hemorrhage), the appearance of
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves First Supplemental Test for Chagas Disease
2. FDA Approves Erwinaze to Treat a Form of Leukemia
3. FDA Approves New York Blood Centers HEMACORD™ for Stem Cell Transplantation
4. FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
5. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
6. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
7. FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
8. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
9. FDA Approves Onfi To Treat Severe Type of Seizures
10. FDA Approves Longer Duration Efficacy and Safety for EUFLEXXA®
11. FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)...  A new analysis of Centers for Medicare and Medicaid ... that 81 percent of seniors chose lower-cost preferred pharmacy ... certain pharmacies. The findings were released by Drug ... the foundation of Medicare Part D," said Pharmaceutical Care ...
(Date:1/23/2015)... 23, 2015  MedScope ( www.medscope.org ), the leading provider ... 2015 Connected World magazine Connected World Award ... that can be used anywhere, anytime. The nomination was ... In nominating MedScope, Landon Garner , Director ...
(Date:1/23/2015)... ORLANDO, Fla. and DUBLIN , ... of the agreement with KRS Global Biotechnology, Inc. for the ... will be compounded for shipment in the United ... 503B FDA approved Outsourcing Facility capable of compounding naltrexone tablets ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... PHILADELPHIA, August 24, 2010 ... ... var shortURL = ""; BitlyCB.alertResponse ... need to grab the first one. for (var r in data.results) { first_result = data.results[r]; break; } ...
... TSI Healthcare, a local and national leader in ... physician practices, was recognized for the second consecutive year ... listing. TSI is ranked among the largest and most ... (#2), NextGen Healthcare® (#29), 3M Health® (#17) and McKesson® ...
Cached Medicine Technology:Pentasa(R) - Shire Receives Ruling From FDA on Citizen's Petition 2Pentasa(R) - Shire Receives Ruling From FDA on Citizen's Petition 3Pentasa(R) - Shire Receives Ruling From FDA on Citizen's Petition 4Pentasa(R) - Shire Receives Ruling From FDA on Citizen's Petition 5Pentasa(R) - Shire Receives Ruling From FDA on Citizen's Petition 6Pentasa(R) - Shire Receives Ruling From FDA on Citizen's Petition 7TSI Healthcare Again Recognized in "Healthcare Informatics TOP 100" 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Gabe’s Chemo Duck Program ... App, the first app ever created for kids with cancer. The ... phones and devices, is filled with enjoyable games to help children ... treatments. The free app helps to keep kids entertained, educated and ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... available in French . , "It is high time ... help people who suffer from this disease," says Dr. Jean Bourbeau, ... Montreal Chest Institute of the MUHC, and lead investigator of CanCOLD ... for Cardiovascular and Pulmonary Research, University of British Columbia. As much ...
... RESTON, Va.On April 16, the President signed a bill ... rates. Although a positive step, the medical communityalong with ... coverage for critical diagnostic imaging tests and therapeutics. ... that the President has signed a bill to delay ...
... 2010 -- A number of updated guidelines are presented at ... held in Barcelona, from 16 through 20 April. The abridged ... extended text documents will also be available in Barcelona to ... is one of the core activities of the organisation. Close ...
... remission after in-patient treatment, study finds , FRIDAY, ... is common among patients after they,ve been hospitalized ... study. , The disorder is characterized by chronic ... and unstable interpersonal relationships. , The study included ...
... valve within the valve might help high-risk patients, researchers ... an artificial heart valve derived from a cow or ... mechanical valve inside the artificial valve could be an ... the new valve opens and functions similarly to the ...
... Adding ,power-steering, to exercises improved movement, quality of life, researchers ... can help stroke patients make small but significant improvements in ... outlook on life, new research finds. , The study, ... April 16 in the New England Journal of Medicine ...
Cached Medicine News:Health News:MUHC leads pan-Canadian initiative on respiratory disease 2Health News:SNM applauds temporary freeze on Medicare cuts 2Health News:EAU launches new and updated clinical guidelines for 2010 2Health News:Hospitalization Appears to Help Personality Disorder Patients 2Health News:Robot-Aided Therapy Can Help Patients Years After Stroke 2
The CALBIOTECH, INC. (CBI), Mumps IgM ELISA tests system is an enzyme linked immunosorbent assay (ELISA) for the detection of IgM class antibodies to Mumps in human serum or plasma....
The DSL-05-10-MUG Mumps IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgG-class antibodies to Mumps Virus in human serum. This assay is intended for in...
... has a closed-cell design that creates a tightly ... restore the inner diameter of a carotid artery, ... reduce the release of fatty debris (emboli) from ... can lead to stroke., ,The Xact stent is ...
... With BareWire technology, the wire crosses the ... delivery catheter. All other actions, including filter ... placement then occur over the wire., ,Emboshield ... break off during a carotid stenting procedure, ...
Medicine Products: